| 000 | 01623 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250511230833.0 | ||
| 264 | 0 | _c19901204 | |
| 008 | 199012s 0 0 eng d | ||
| 022 | _a0012-1797 | ||
| 024 | 7 |
_a10.2337/diab.39.2.204 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMandrup-Poulsen, T | |
| 245 | 0 | 0 |
_aLack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients. The Canadian-European Randomized Control Trial Group. _h[electronic resource] |
| 260 |
_bDiabetes _cFeb 1990 |
||
| 300 |
_a204-10 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAutoantibodies _ximmunology |
| 650 | 0 | 4 |
_aCyclosporins _xtherapeutic use |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xdrug therapy |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHLA-DR Antigens _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunosuppression Therapy |
| 650 | 0 | 4 |
_aInsulin Antibodies _ximmunology |
| 650 | 0 | 4 |
_aIslets of Langerhans _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aProspective Studies |
| 700 | 1 | _aMølvig, J | |
| 700 | 1 | _aAndersen, H U | |
| 700 | 1 | _aHelqvist, S | |
| 700 | 1 | _aSpinas, G A | |
| 700 | 1 | _aMunck, M | |
| 773 | 0 |
_tDiabetes _gvol. 39 _gno. 2 _gp. 204-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2337/diab.39.2.204 _zAvailable from publisher's website |
| 999 |
_c2233249 _d2233249 |
||